Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 769-775

  Cardili, R N ^a   Alves, T G ^b   Freitas, J C O C ^c   Soares, C P ^b   Mendes Junior, C T ^a   Soares, E G ^a   Donadi, E A ^a   Silva Souza, C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

autoimmunity; HLA G; inflammation; psoriasis

Indexed keywords

HLA G ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMIS; DISEASE SEVERITY; EPIDERMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS SEVERITY INDEX; SKIN BIOPSY;

ADOLESCENT; ADULT; AGED; EPIDERMIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN; YOUNG ADULT;

EID: 77957086233     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09917.x     Document Type: Article

References (38)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med 1995 332 : 581 588.
2. Espinoza LR, Cuéllar ML, Silveira LH. Psoriatic arthritis. Curr Opin Rheumatol 1992 4 : 470 478.
3. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007 445 : 866 873.
4. Gotlieb AB. Immunologic mechanisms in psoriasis. J Invest Dermatol 1990 95 : 18 19S.
5. Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon gamma, interleukin-2 and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999 113 : 752 759.
6. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008 128 : 1207 1211.
7. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992 89 : 3947 3951.
8. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994 15 : 5516 5524.
9. Paul P, Cabestre FA, Ibrahim EC et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000 61 : 1138 1149.
10. Kovats S, Main EK, Librach C et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990 248 : 220 223.
11. Riteau B, Menier C, Khalil-Daher S et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001 13 : 193 201.
12. Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000 30 : 586 593.
13. Puppo F, Contini P, Ghio M, Indiveri F. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction. Sci World J 2002 12 : 421 423.
14. Contini P, Ghio M, Poggi A et al. Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003 33 : 125 134.
15. Nikolic B, Sykes M. Clonal deletion as a mechanism of transplantation tolerance. J Heart Lung Transplant 1996 15 : 1171 1178.
16. Clark RA. Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 2010 130 : 362 370.
17. Wiendl H, Mitsdoerffer M, Hofmeister V et al. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002 168 : 4772 4780.
18. Urosevic M. HLA-G in the skin - friend or foe? Semin Cancer Biol 2007 17 : 480 484.
19. Paul P, Rouas-Freiss N, Khalil-Daher I et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998 95 : 4510 4515.
20. Maier S, Geraghty DE, Weiss EH. Expression and regulation of HLA-G in human glioma cell lines. Transplant Proc 1999 31 : 1849 1853.
21. Castelli EC, Mendes-Junior CT, Viana deCamargoJL, Donadi EA. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 2008 72 : 149 157.
22. Lozano JM, González R, Kindelán JM et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002 16 : 347 351.
23. Onno M, Pangault C, Le FriecG et al. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000 164 : 6426 6434.
24. Creput C, Le FriecG, Bahri R et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 2003 64 : 1033 1038.
25. Lila N, Amrein C, Guillemain R et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002 105 : 1949 1954.
26. Crispim JC, Duarte RA, Soares CP et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008 18 : 361 367.
27. Torres MI, Le DiscordeM, Lorite P et al. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol 2004 16 : 579 583.
28. Verbruggen LA, Rebmann V, Demanet C et al. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006 67 : 561 567.
29. Wiendl H, Feger U, Mittelbronn M et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 2005 128 : 2689 2704.
30. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008 29 : 125 132.
31. Khosrotehrani K, Le DanffC, Reynaud-Mendel B et al. HLA-G expression in atopic dermatitis. J Invest Dermatol 2001 117 : 750 752.
32. Wastowski IJ, Sampaio-Barros PD, Amstalden EM et al. HLA-G expression in the skin of patients with systemic sclerosis. J Rheumatol 2009 36 : 1230 1234.
33. Aractingi S, Briand N, Le DanffC et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2001 159 : 71 7.
34. Ulbrecht M, Rehberger B, Strobel I et al. HLA-G: expression in human keratinocytes in vitro and human skin in vivo. Eur J Immunol 1994 24 : 176 180.
35. Moreau P, Flajollet S, Carosella ED. Nonclassical transcriptional regulation of HLA-G: an update. J Cell Mol Med 2009 13 : 2973 2989.
36. Jacob SE, Nassiri M, Kerdel FA, Vincek V. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm 2003 12 : 309 313.
37. Castelli EC, Moreau P, Oya eChiromatzoAO et al. In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes. Hum Immunol 2009 70 : 1020 1025.
38. Borghi A, Fogli E, Stignani M et al. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 2008 300 : 551 559.